Showing results (521-530 of 547) with videos related to

Sort By:
Pageof 55
Rheumatology (Oxford, England)|October 26, 2024
Contributors to organ damage in childhood lupus: corticosteroid use and disease activityMaria Hanif, Chandni Sarker, Eslam Al-Abadi, et al.
Rheumatology (Oxford, England)|December 11, 2021
Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupusEve M D Smith, Kukatharmini Tharmaratnam, Eslam Al-Abadi, et al.
Science (New York, N.Y.)|September 27, 1991
Images from galileo of the venus cloud deckM J Belton, P J Gierasch, M D Smith, et al.
Clinical Immunology (Orlando, Fla.)|April 11, 2024
Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task forceE M D Smith, A Aggarwal, J Ainsworth, et al.
Journal of Geophysical Research. Planets|December 30, 2022
Global Vertical Distribution of Water Vapor on Mars: Results From 3.5 Years of ExoMars-TGO/NOMAD Science OperationsS Aoki, A C Vandaele, F Daerden, et al.
Clinical Immunology (Orlando, Fla.)|March 19, 2023
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)E M D Smith, A Aggarwal, J Ainsworth, et al.
Rheumatology (Oxford, England)|May 9, 2022
Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLEAmandine Charras, Sam Haldenby, Eve M D Smith, et al.
Rheumatology (Oxford, England)|January 20, 2026
Validating treat-to-target endpoints in childhood lupus: data-driven sensitivity analyses from the UK JSLE cohort studyChandni Sarker, Andrea L Jorgensen, Kukatharmini Tharmaratnam, et al.
Rheumatology (Oxford, England)|March 10, 2021
Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort StudyEve M D Smith, Sajida Rasul, Coziana Ciurtin, et al.
Pageof 55